Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. News Desk 2018 Message Board

Model N to Present CPQ and Tendering Strategies at

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 617763
(Total Views: 320)
Posted On: 02/20/2017 2:15:02 AM
Avatar
Posted By: News Desk 2018
Model N to Present CPQ and Tendering Strategies at the 4th Annual Medical Device Commercial Leaders Forum

REDWOOD CITY, CA --(Marketwired - February 20, 2017) - Model N, Inc . ( NYSE : MODN ), the leading provider of cloud-based revenue management solutions to life sciences, high tech and manufacturing companies, today announced its platinum sponsorship for the 4th Annual Medical Device Commercial Leaders Forum. The Forum is being held February 20-22, 2017, at the Crowne Plaza Hotel in Zurich, Switzerland.

"The MedTech industry has reached an inflection point with healthcare providers shifting their demands on pricing, sales and contracting operations," said Marc Baumgartner, senior vice president and general manager of life sciences at Model N. "We look forward to sponsoring the forum for our third year and sharing insights into how MedTech companies can optimize their commercial strategies for success."

Model N is a well-recognized thought leader in global pricing and profit optimization for the Medical Device industry. The company brings deep industry expertise and has a top-tier medical device customer roster including Johnson & Johnson, Novartis and Boston Scientific. During the forum, Model N will share industry trends, product demos and best practices that are reshaping selling and pricing in MedTech. In addition, Model N will be at booth #3 to demonstrate its Configure Price Quote (CPQ) solution and Global Tender Management solution . These end-to-end SaaS solutions allow enterprises to maximize revenue by integrating and automating the complexities of the pricing and quoting processes, contract management and rebate management. Model N solutions help MedTech companies win more deals at the best price while reducing unnecessary risks.

"We are thrilled to have Model N as a platinum sponsor for the 4th Annual Medical Device Commercial Leaders Forum ," said Geoff Cable, CEO of NextLevel Pharma. "As experts on pricing and profit optimization, they will bring unique insights to the forum that will help MedTech companies maximize revenues and margins."

The Medical Device Commercial Leaders Forum brings together senior executives from leading life sciences companies looking to drive the commercial performance of their medical device business units and departments forward, develop game-changing sales and marketing strategies and enhance their key opinion leaders and customer engagement at all levels.

Please join Model N on Monday, February 20, 2017, at 12:10 p.m. CET for a presentation on "CPQ and Tender Management: How Can I Optimize my Commercial Strategy?" or stop by booth #3 for more information.

About Model N Model N is the leader in Revenue Management solutions. Driving mission critical business processes such as configure, price and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance, Model N solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the complex business needs of the world's leading brands in life sciences, technology and manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com .

Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

For media inquiries, please contact: Model N, Inc. pr@modeln.com



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us